The top after-market NASDAQ stock market gainers are: LaserCard, Incyte, Adobe Systems, Sonus Networks, Myriad Genetics, YRC Worldwide, SciClone Pharmaceuticals, Perficient, MannKind, and Web.com Group.

LaserCard Corp. (LCRD) advanced 38.43 percent to $6.16 in the after-market trading. The company said it agreed to be acquired by ASSA ABLOY AB, at a price of $6.25 a share through a cash tender offer. LaserCard would become part of ASSA ABLOY's HID Global business, after the completion of the $80 million transaction, expected in LaserCard's fiscal fourth quarter.

Incyte Corp. (INCY) soared 5.40 percent to $16 in the after-hours session. The company said a late stage study of a drug for treating myelofibrosis, a type of blood cancer that affects the bone marrow, showed positive results with perceptibly higher reduction in spleen volume compared with placebo. Incyte is developing the drug along with Novartis AG (NVS), which has exclusive rights to develop and sell the drug outside of the U.S.

In the late stage study COMFORT-I, the primary endpoint was the response rate defined as the percentage of myelofibrosis-patients achieving a 35 percent or greater reduction in spleen volume at 24 weeks. The results showed that the drug had a response rate of 42 percent in patients, compared with less than 1 percent randomized to a placebo, at the end of 24 weeks.

Adobe Systems Inc. (ADBE) jumped 5.29 percent to $30.72 in the after-market trading. The company's fourth quarter adjusted profit was $285.7 million or 56 cents a share, up from $206.8 million or 39 cents a share last year. Revenue rose 33 percent to $1.01 billion. Analysts had expected profit of 52 cents a share on revenue of $988.07 million.

Adobe Systems expects first quarter adjusted earnings of 54 cents to 59 cents a share and revenue of $1 billion to $1.05 billion. Analysts expect profit of 51 cents a share on revenue of $992.19 million.

Sonus Networks, Inc. (SONS) surged 3.85 percent to $2.70 in the after-hours session.

Myriad Genetics Inc. (MYGN) climbed 3.72 percent to $23.71 in the after-market trading. The company said it launched PANEXIA, a predictive medicine product for hereditary pancreatic and related cancers, which assesses a person's risk of developing pancreatic cancer later in life. PANEXIA is a comprehensive analysis of the PALB2 and BRCA2 genes.

YRC Worldwide Inc. (YRCW) improved 2.60 percent to $3.95 in the after-hours session.

SciClone Pharmaceuticals, Inc. (SCLN) grew 2.47 percent to $4.15 in the after-market trading.

Perficient Inc. (PRFT) gained 2.40 percent to $11.97 in the after-hours session.

MannKind Corp. (MNKD) increased 1.94 percent to $8.42 in the after-market trading.

Web.com Group, Inc. (WWWW) rose 1.75 percent to $8.86 in the after-hours session.

NASDAQ Stock Market Cancer Cancer Adobe